Larvol Delta - Autobahn-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-ABX002-as-an-Adjunctive-Treatment-for-Bipolar-Depression

ABX-002 - Autobahn Therap

https://www.businesswire.com/news/home/20241022481380/en/Autobahn-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-ABX-002-as-an-Adjunctive-Treatment-for-Bipolar-Depression

Oct 22, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next